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Adoptive T-Cell therapy is a growing field for cancer treatment using the patient’s immune system to battle the 
cancer cells. Tumor specific T cells are either isolated from a tumor or created by modifying the T cells and after 
expansion are administered to the patient. The modifications include adding specific T cell receptors (TCR) or 
chimeric antigen receptors (CAR) by way of retroviral vector, lentiviral vector, or other method. One method is to 
use PG13 cells, which are derivatives of NIH3T3 mouse fibroblasts, to stably produce a retroviral vector that is 
used to transduce the T cell. PG13 cells are anchorage dependent cells that grow in roller bottles or cell 
factories to produce the viral vector and recently in a fixed bed bioreactor. To improve the production of the viral 
vector we explore the possibility of its production using PG13 cells grown on microcarriers in a bioreactor. 
Microcarriers are small, approximately 100-300 µm, charged beads that support the attachment of the cells and 
are suspended in the growth media in the bioreactor that provide controlled growth conditions. In this way 
parameters, such as oxygen concentration, pH, and nutrient are monitored and controlled. The result is higher 
cell concentration and consequently virus titer.  There was no effect on the specific virus titer or the efficacy of 
the vector in transducing t cells indicating that using microcarriers in a bioreactor is a good method for scaling 
up stable production of gamma retroviral vector in PG13 cells.   
 
